Haloxazolam

卤沙唑仑

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHaloxazolam
Drug Alias NameHaloxazolamum海洛唑仑卤恶唑他卤恶唑仑卤┭唑仑 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSleep Initiation and Maintenance Disorders
Global Approved IndicationsSleep Initiation and Maintenance Disorders
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1980/01/01
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsSleep Initiation and Maintenance Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN03AEN05BAN05CD
Related LinksWikipediaDrugBankKEGG